Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,575.83
(
-0.74%
)
US TECH 100
23,615.20
(
-0.76%
)
Dow Jones
45,802.76
(
-0.91%
)
Brent Oil
105.66
(
-0.87%
)
Bitcoin
69,705.47
(
-2.16%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: tony111 post# 74865

Monday, 03/23/2009 12:54:06 AM

Monday, March 23, 2009 12:54:06 AM

Post# of 257259

Too bad inform-1 does not have a 14+14 regimen. Otherwise we could compare the data with prove-3 to speculate on the role of interferon+ribavirin.

Patience! You’ll have the data you seek in due course.

As ghmm has noted, INFORM-1 will be followed by INFORM-2 (and probably INFORM-3 and -4) as investigators gain more confidence in the safety of the tested combinations.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today